Arcis Biotechnology's Series C Round

Arcis Biotechnology raised a round of funding on July 30, 2014. Investors include Calculus Capital.

Arcis Biotechnology has developed fast nucleic acid sample preparation technology that allows the extraction and stabilization of RNA for up to 26 days. The firm's ready-to-use Arcis DNA Prep and Arci…

Articles about Arcis Biotechnology's Series C Round: